IDEAYA Biosciences enters clinical collaboration with Genentech
IDEAYA Biosciences (IDYA) announces a clinical collaboration with Genentech focused on MTAP-deleted KRAS G12D-mutant pancreatic cancer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
IDEAYA Biosciences (IDYA) announces a clinical collaboration with Genentech focused on MTAP-deleted KRAS G12D-mutant pancreatic cancer.